Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus

Calabrese L , Fleischer AB . Thalidomide current and potential clinical applications . Am J Med 2000; 108: 487–495 .

Knop J , Bonsmann G , Happle R et al. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus . Br J Dermatol 1983; 108: 461–466 .

Duong DJ , Spigel GT , Moxley RT 3rd , Gaspari AA . American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus . Arch Dermatol 1999; 135: 1079–1087 .

Ordi-Ros J , Cortes F , Cucurull E , Mauri M , Bujan S , Vilardell M . Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy . J Rheumatol 2000; 27: 1429–1433 .

Karim MY , Ruiz-Irastorza G , Khamashta MA , Hughes GR . Update on therapy—thalidomide in the treatment of lupus . Lupus 2001; 10: 188–192 .

Petter C . Early fœtal thrombosis induced by thalidomide in mouse: possible explanation of teratogenicity . Experiencia 1977; 33: 1384–1386 .

Genvo MF , Faure M , Thivolet J . Traitement de l'aphthose par la thalidomide et la colchicine . Dermatologica 1984; 168: 182–188 .

Flageul B , Wallach D , Cavelier-Balloy B , Bachelez H , Carsuzaa F , Dubertret L . Thalidomide et thromboses . Ann Dermatol Venerol 2000; 127: 171–174 .

Zangari M , Anaissie E , Barlogie B et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy . Blood 2001; 98: 1614–1615 .

Osman K , Comenzo R , Rajkumar SV . Deep venous thrombosis and thalidomide therapy for multiple myeloma . New Engl J Med 2001; 344: 1951–1952 .

Camba L , Peccatori J , Pescarollo A , Tresoldi M , Corradini P , Bregni M . Thalidomide and thrombosis in patients with multiple myeloma . Haematologica 2001; 86: 1108–1109 .

Pouaha J , Martin S , Trechot P , Truchetet F , Barbaud A , Schmutz JL . Thalidomide et thromboses: trois observations . Presse Med 2001; 30: 1008–1009 .

Esteve E , Legac E . Thrombose veineuse et embolie pulmonaire au cours d'une aphtose traitée par thalidomide . Ann Dermatol Venerol 2001; 128: 148–149 .

Hamuryudan V , Mat C , Saip S et al. Thalidomide in the treatment of mucocutaneous lesions of the Behcet's syndrome: a randomized, double blind, placebo-controlled trial . Ann Intern Med 1998; 128: 443–450 .

Clark TE , Edom N , Larson J , Lindsey LJ . Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing . Drug Safety 2001; 24: 87–117 .

Geitz H , Handt S , Zwingenberger K . Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade . Immunopharmacology 1996; 31: 213–221 .

d'Amato RJ , Loughman MS , Flynn E , Folkman J . Thalidomide is an inhibitor of angiogenesis . Proc Natl Acad Sci USA 1994; 91: 4082–4085 .

Barlogie B , Desikan R , Eddlemon P et al. Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients . Blood 2001; 98: 492–494 .

Jewell ML , McCauliffe DP . Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment . J Am Acad Dermatol 2000; 42: 983–987 .

Rahman P , Gladman DD , Urowitz MB . Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus . J Rheumatol 1998; 25: 1716–1719 .

Petri M . Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective . Scand J Rheumatol 1996; 25: 191–193 .

Edwards MH , Pierangeli S , Liu X , Barker JH , Anderson G , Harris EN . Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice . Circulation 1997; 96: 4380–4384 .

Sontheimer RD . Systemic lupus erythematosus and the skin. In: Lahita RG (ed). Systemic Lupus Erythematosus, 3rd edn. Academic Press: San Diego, CA , 1999, pp 631–655.

Buyon JP , Wallace DJ . The use of exogenous estrogens, endocrine system, and urogenital tract. In: Wallace DJ , Hahn BH (eds). Dubois' Lupus Erythematosus, 6th edn. Lippincott, Williams and Wilkins: Philadelphia PA , 2002, pp 821–841.

Julkunen HA , Kaaja R , Friman C . Contraceptive practice in women with systemic lupus erythematosus . Br J Rheumatol 1993; 32: 227–230 .

Petri M . Epidemiology of the antiphospholipid antibody syndrome . J Autoimmun 2000; 15: 145–151 .

Fonseca E , Alvarez R , Gonzalez MR , Pascual D . Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus . Lupus 1992; 1: 265–268 .

Tebbe B , Orfanos CE . Anticardiolipin-Antikörper beim kutanen Lupus erythematodes . Hautarzt 1992; 43: 130–133 .

Mayou SC , Wojnarowska F , Lovell CR , Asherson RA , Leigh IM . Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus—their clinical significance . Clin Exp Dermatol 1988; 13: 389–392 .

Kind P , Schuppe HC , Jung KP , Degitz K , Lakomek HJ , Goerz G . Kutaner Lupus erythematodes und Kardiolipin-Antikörper . Hautarzt 1992; 43: 126–129 .

Ruffatti A , Veller-Fornasa C , Patrassi GM et al. Anticardiolipin antibodies and antiphospholipid syndrome in chronic discoid lupus erythematosus . Clin Rheumatol 1995; 14: 402–404 .

Berth-Jones J , Hutchinson PE , Wicks AC , Warren J , Mitchell VE . Discoid lupus erythematosus associated with the anticardiolipin syndrome . Br J Dermatol 1989; 120: 469–470 .

Crofford LJ , Oates JC , McCune WJ et al. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors . A report of four cases. Arthritis Rheum 2000; 43: 1891–1896 .

Jorenby DE , Leischow SJ , Nides MA et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation . New Engl J Med 1999; 340: 685–691 .

The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus . New Engl J Med 1991; 324: 150–154 .

Petri M , Roubenoff R , Dallal GE , Nadeau MR , Selhub J , Rosenberg IH . Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus . Lancet 1996; 348: 1120–1124 .

Pitsavos C , Stefanadis C , Toutouzas P . Contraception in women at high risk or with established cardiovascular disease . Ann NY Acad Sci 2000; 900: 215–227 .

Chabbert-Buffet N , Blétry O , Clauvel JP et al. Pregnane progestin is a safe contraception in patients with systemic lupus erythematosus (abstract) . Arthritis Rheum 1997; 40(Suppl): S325–S325 .